This information is considered to be inside information pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/bergenbio-reports-third-quarter-2022-financial-results-and-provides-business-update-301677958.html